Search

In conversation with Amanda Cameron

We spoke to Amanda Cameron about her fascinating career in aesthetics, from her early clinical days as a nurse through to her experience in the field of publishing. You are legendary in the world of aesthetic nursing – can you...

Support groups for hidradenitis suppurativa

Hidradenitis suppurativa (HS) is an inflammatory condition characterised by painful inflamed nodules in the apocrine regions of the body. It follows a chronic relapsing clinical course and is a very difficult condition to treat. It has an estimated prevalence of...

Xanthelasma

Although the lesion known as Xanthelasma was first described by Addison and Gall in 1851 [1] it was recorded some 300 years previously in the famous painting of the Mona Lisa by Leonardo da Vinci. In this painting, Leonardo da...

Recent developments in hyaluronic acid research

Hyaluronic acid has a role in many medical specialties, not just aesthetics. Anna Baker takes us through the latest evidence and therapeutic indications. The evidence and demand for hyaluronic acid (HA) based technologies continues to expand and evolve across a...

Online connections in a post-COVID world

Looking back at the pandemic, it has brought us unexpected friendships. The lack of direct interpersonal communication, meetings, parties and hugs increased the role of digital sources of contact which used to play a less important role in our lives....

The flora of Culloden Field: Healing plants of a wounded land

The Battle of Culloden, fought on 16 April 1746, marked the end of the Jacobite uprising in Scotland. It was a devastating clash between the Jacobite forces led by Charles Edward Stuart (‘Bonnie Prince Charlie’) and the British army under...

In conversation with Professor David Sines

In January 2016 a new voluntary regulatory register was established – the Joint Council for Cosmetic Practitioners (JCCP), chaired by Professor David Sines. Since that time the JCCP has met with challenges from many within the aesthetics industry. We spoke...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Botulinum toxin and dermal filler treatment for facial deformity: an analysis of patient satisfaction

Dermal fillers and botulinum toxin are being increasingly used to treat facial deformities but are patients satisfied with the results? Facial deformity can result in low confidence and self-esteem amongst patients due to cosmetic and functional difficulties [1]. There is...

Lasers and the skin

Laser is an acronym for Light Amplification by Stimulated Emission of Radiation. Lasers have revolutionised the treatment of many skin conditions and are being used both in terms of a medical and an aesthetic context. Laser technology has been advancing...

Improving cosmesis after breast implant removal

Removing breast implants has a profound effect on the patient’s appearance; in this article the authors, both expert breast surgeons, discuss how to optimise the cosmetic result. Removing breast implants has a profound effect on the patient’s appearance and we...